Methotrexate and bone mass

Clinical and Experimental Rheumatology

Volumn 18, Issue 5 SUPPL. 21, 2000, Pages

  Mazzantini, M ^a   Di Munno, O ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bone mass; Bone turnover; Methotrexate; Osteoporosis; Rheumatoid arthritis; Stress fractures

Indexed keywords

CALCIUM; ESTROGEN; GLUCOCORTICOID; METHOTREXATE; PREDNISONE; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE DISEASE; BONE MASS; BONE PAIN; BONE TURNOVER; CLINICAL TRIAL; DENSITOMETRY; DOSE RESPONSE; DRUG MECHANISM; FRACTURE; HUMAN; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0033773606     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Evidence of cytotoxic activity of polyglutamate derivatives of methotrexate
2. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: A controlled clinical trial
3. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update
4. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis: A meta-analysis of published clinical trials
5. The mechanisms of action of methotrexate in rheumatoid arthritis: The search continues
6. Methotrexate inhibits macrophage activation as well as vascular and cellular anflammatory events in rat adjuvant-induced arthritis
7. Methotrexate suppresses passive adjuvant arthritis: Studies on the metabolism of methotrexate in mononuclear cells derived from normal and adjuvant arthritic rats
8. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients
9. Colchicine and methotrexate reduce leucocyte adherence and emigration in rat mesenteric venules
10. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells
11. The anti-inflammatory mechanism of methotrexate: Increased adenosine release at inflamed sites diminishes leucocyte accumulation in an in vivo model of inflammation
12. Inhibition of TNFα expression by adenosine: Role of A3 adenosine receptors
13. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: A mechanism for methotrexate-induced nodulosis in rheumatoid arthritis
14. Interleukin-1 (IL-1) receptor antagonist, soluble tumor necrosis factors receptors, IL-1β and IL-8 - Markers of remission in rheumatoid arthrifts during treatment with methotrexate
15. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes
16. Osteoporotic fractures secondary to methotrexate therapy of leukemia in remission
17. Methotrexate induced bone pain in childhood leukemia
18. Fractures in children treated with methotrexate for leukemia
19. Methotrexate osteopathy
20. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems
21. Methotrexate osteopathy in patients with osteosarcoma
22. Bone mass after treatment for acute lymphoblastic leukemia in childhood
23. Methotrexate osteopathy in rheumatic disease
24. Effects of chemotherapeutic agents on bone
25. Cytotoxic drugs for non-neoplastic disease
26. Multiple stress fractures in the hindfoot in rheumatoid arthritis
27. Insufficiency fractures of the distal tibia misdiagnosed as cellulitis in three patients with rheumatoid arthritis
28. Insufficiency fracture of the distal tibia mimicking arthritis in a rheumatoid arthritis patient. The possible role of methotrexate treatment
29. Possible role of methotrexate in the distal tibiae fractures in a patient with rheumatoid arthritis
30. Methotrexate osteopathy, does it exist ?
31. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis
32. Multiple stress fractures in a scleroderma patient on methotrexate therapy
33. Stress fractures of the tibia in the elderly associated with knee deformity
34. Insufficiency and stress fractures of the long bones occurring in patients with rheumatoid arthritis
35. Stress fractures of the lower limb in patients with rheumatoid arthritis
36. Insufficiency fractures of the tibia and fibula
37. Effect of low dose methotrexate on osteogenesis
38. Bone nonunion after osteotomy in patients treated with methotrexate
39. Effect of methotrexate on distraction angiogenesis
40. Methotrexate conctentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients
41. The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats
42. The effect of methotrexate on mouse cells in culture
43. Effects of methotrexate on human osteoblasts in vitro: Modulation by 1,25-dihydroxyvitamin D3
44. In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts
45. Effect of methotrexate and sulphasalazine on UMR 106 rat osteosarcoma cells
46. Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats
47. Short-term low-dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant-induced arthritis
48. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis
49. Effect of methotrexate on bone density and calcium homeostasis in rheumatoid arthritis
50. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis
51. Methotrexate on polymyalgia rheumatica: Preliminary results of an open, rendomized study
52. Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis
53. Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate